Menu
biotium logo
Antibody Finder
Menu
November 20, 2020

Biotium Now Offering Anti-DIG and Anti-DNP CF® Dye Antibodies

By: NeuralabAdmin

New conjugates offer optimal fluorescent detection of DNP and DIG tagged nucleotides and proteins.

Fremont, CA, November 20, 2020: Biotium is announcing the release of anti-DIG and anti-DNP antibodies conjugated to a variety of CF® dyes and HRP. These new CF® dye antibodies offer optimal detection of small haptens digoxigenin (DIG) and dinitrophenol (DNP) which are commonly used as non-radioactive labels for nucleotides, proteins, and other biological molecules.
CF® dyes are a series of extremely bright and photostable fluorescent dyes developed in house by industry-leading chemists at Biotium. CF® dyes are available in over 30 different colors from blue to near-IR, and offer superior brightness and signal-to-noise when compared to other commercially available fluorescent dyes. The release of these DIG and DNP hapten antibodies offers researchers the optimal performance of CF® dyes in addition to expanding multiplexing opportunities.

The DIG Polyclonal Goat Antibody and DNP Polyclonal Rabbit Antibody will be offered with 6 CF® dyes from blue to far-red as well as HRP. CF® dye conjugates for both antibodies will be offered in 250 uL and 100 uL sizes, priced at $325 and $150 respectively. The HRP conjugates will be offered in a 100 uL size priced at $250 dollars. Biotium also offers a Mix-n-Stain™ DNP Antibody Labeling Kit and a Mix-n-Stain™ DIG Antibody Labeling Kit for rapid and efficient IgG labeling. Digoxigenin-dUTP is also available for enzymatic incorporation into DNA.


About

Biotium is a leading life science reagent manufacturer and supplier devoted to providing high-quality and innovative fluorescent tools that fuel scientific discovery. Our collaborative team of experienced chemists and biologists, who are at the forefront of fluorescent dye design, apply chemistry-based principles toward producing solutions for unmet challenges in life science and medical research. Since its founding in 2001, Biotium has developed over 30 patented technologies that have been licensed out to leading life science technology companies worldwide.

Media Contact: